Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...

Bristol Myers Squibb (BMY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

We recently published a list of 10 Stocks That Are Close To Becoming Dividend Aristocrats. In this article, we are going to ...

Income investors are drawn to Aristocrats because these stocks have consistently increased their dividends for decades.

Bristol-Myers Squibb (NYSE: BMY) is the kind of stock that potentially has a lot to offer to investors looking for ...

The issuer is solely responsible for the content of this announcement.

Wolfe Research has recently initiated Bristol-Myers Squibb Co (BMY) stock to Peer Perform rating, as announced on November 15, 2024, according to Finviz. Earlier, on November 13, 2024, Daiwa ...

There is more to the comparison, and in the sections below, we discuss why we think BMY will outperform JNJ in the next three ...

Bristol-Myers Squibb's price continues to rise due to a confluence of factors, not the least of which is an earnings surprise in Q3 2024. Learn more on BMY stock here.

It's been a challenging past few years for Bristol Myers Squibb (NYSE: BMY). The company's financial results dipped following ...

Generating thousands of dollars of recurring income can be a great way to make you less reliant on employment income or retirement benefits. While many investors have been focusing on growth stocks ...

On Tuesday, Bristol-Myers Squibb Co (BMY) stock saw a modest uptick, ending the day at $58.23 which represents a slight increase of $1.43 or 2.52% from the prior close of $56.8. The stock opened at ...